DOCSLIB.ORG

Musculoskeletal Pain

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Musculoskeletal Pain Musculoskeletal Pain Kathryn Albers Mechanisms and Clinical Presentation of Pain November 4, 2019 Queme et al., (2017). Peripheral mechanisms of ischemic myalgia. Frontiers in Cellular Neuroscience. Mense et al., (2010). Functional anatomy of muscle: Muscle, nociceptors and afferent fibers. In MusclePain: Understanding the Mechanisms. The musculoskeletal system consists of the body's bones, muscles, tendons, ligaments, joints, and cartilage. A tendon is a fibrous connective tissue that attaches muscle to bone (serves to move the bone). A ligament is a fibrous connective tissue that attaches bone to bone (serves to hold structures together). Major health problems presenting with muscle ache/pain are addressed by NIAMS, National Institutes of Arthritis, Musculoskeletal and Skin Diseases. Neck pain Temperomandibular joint pain Fibromyalgia Shoulder pain Low back pain Skeletal muscle comprises 40% of body weight. Muscles produce several hundred myokines; cytokines, growth factors, proteoglycan peptides released by muscle cells (myocytes) in response to muscular contractions. They have autocrine, paracrine and/or endocrine effects on muscle mass, fat metabolism, inflammation…. Lee and Jun. (2019) Role of myokines in regulating skeletal muscle mass and function. Frontiers in Physiology 10. Musculoskeletal Pain Overview Physical activity leads to contraction-induced mechanical and metabolic stimuli in muscle tissue. These stimuli activate receptors on terminals of thinly myelinated and unmyelinated DRG neurons that project to the DH of the spinal cord. • Chronic muscle pain can be regional (back or neck) or whole body with tender points spread over the body (fibromyalgia). • In contrast to cutaneous nociceptive stimuli, sensations from deep tissue (muscle, vascular, fascia) pain are dull, aching and poorly localized. Muscle pain can also elicit a drop in blood pressure, sweating and nausea. • Pain can relate to dysfunction of peripheral perfusion (e.g., peripheral vascular disease) and are often comorbid with altered cardiovascular responses to muscle contraction/exercise (exercise pressor reflex, EPR). Musculoskeletal Pain Overview, continued • Muscle pain (myalgia) can present as • Inflammatory, e.g., rheumatoid arthritis (autoimmune, widespread), exercise-induced • Degenerative/inflammatory – osteoarthritis (localized to joints) • Possibly inflammatory – • fibromyalgia, • low back pain • myofascial (muscle-connective tissue) pain syndrome, where pressure on sensitive points in the muscle (knots) is painful. MPS typically caused by repetitive motions or stress-related muscle tension. Cellular basis of muscle pain: 1. Myositis – general term for inflammation of the muscle. - Injury, infection or autoimmune disease can cause polymyositis. Immune activation generates interleukins, TNF, chemokines, growth factors. 2. Tissue acidosis, a decrease in local tissue pH. - Pain correlates with increased protons (H+) and lactate buildup in muscle/synovial fluid - Infusion of acidic solutions (pH 5.2) into muscle causes mechanical hyperalgesia in human and in rodent models. 3. Dysregulation of metabolite levels - ATP, lactate and protons. Infusion of metabolite soup into muscle is painful. 10 volunteers (6 men/4 women) 0.2ml protons/ATP/lactate infused over 30s under fascia of thumb muscle. Exp Physiol 99.2(2014)368. Findings: • Low conc of protons, lactate and ATP evoked sensations related to fatigue. • Higher conc evoked pain. • Single metabolites evoked no sensations • Interpretations: - Two types of sensory neurons encode metabolites; one detects low concentrations, signals fatigue. The other detects higher conc and signals ‘ache and hot’. - In human, metabolites normally produced by exercise act in combination to activate sensory neurons that signal sensations of fatigue and muscle pain. Do metabolites enhance sensitivity of muscle afferents in chronic disease states, e.g., fibromyalgia? Muscle Morphology Straited (skeletal) – voluntary, ~40% of body weight Cardiac - involuntary Smooth - involuntary connective tissue connective tissue connective tissue Fig. 2.1 From S. Mense et al., Functional Anatomy of Muscle: Muscle, Muscle Nociceptors and Afferent Fibers. S. Mense and R.D. Gerwin (eds.), Muscle Pain: Understanding the Mechanisms, DOI 10.1007/978-3-540-85021-2_2, # Springer-Verlag Berlin Heidelberg 2010 Muscle Innervation e.g., knee Group I-IV nomenclature introduced by DPC Lloyd, 1943. Afferent fiber types • Group Ia, II – assoc with muscle spindles; respond to stretch, changes in muscle length. • Group III – thinly myelinated A delta fibers • Group IV - unmyelinated C fibers Group III/IV afferents primarily project to sc lamina I, II (less so to IV-V). Efferent motor neurons: Alpha – innervate extrafusal fibers and intiate muscle contraction. Gamma – innervate intrafusal muscle fibers in the muscle spindle. Beta motor neurons – innervate both extra- and intra –fusal fibers. Very few of these. Properties of Muscle Nociceptors • Relatively slow conducting, below 20-30 m/s (species dependent) (fastest fibers reach 100 m/s). • Thin myelinated, group III fibers – correspond in conduction velocity to cutaneous Ad fibers. 1.2 - 14 m/s (in mouse) • Unmyelinated group IV fibers – correspond in conduction velocity to cutaneous C fibers. <1.2 m/s (mouse) a-CGRP • Group III and group IV fibers function as chemo-, thermo- and mechano-receptors, functional overlap unclear *. arteriole • Many Group III/IV fibers innervate adventitia of vasculature and perimysium; few innervate muscle fibers**. *Light AR, Perl ER (2003) Unmyelinated afferent fibers are not only for pain anymore. J Comp Neurol 461:140–150. Discusses muscle LTMRs. **Reinert A, Kaske A, Mense S (1998) Inflammation-induced increase in the density of neuropeptide-immunoreactive nerve endings in rat skeletal muscle. Exp Brain Res 121:174–180 Fig. 2.5 From Mense et al., Muscle Pain: Understanding the Mechanisms, DOI 10.1007/978- 3-540-85021-2_2, 2010 That muscle fibers themselves are not supplied by free nerve endings may relate to the clinical experience that muscle cell death is usually not painful, at least not if it occurs slowly, as during muscular dystrophy, polymyositis, or dermatomyositis (skin rash with muscle inflammation). A different situation is tearing of a muscle fiber bundle, which can be extremely painful. Many muscle cells are destroyed simultaneously and release their contents (e.g., K+ ions, ATP) in the interstitial space, from where they can diffuse to nociceptive endings. S. Mense Review: Functional Anatomy of Muscle: Muscle, Nociceptors and Afferent Fibers Membrane receptors associated with nociception are expressed by muscle afferents. Most studied are: Acid Sensing Ion Channels - sensitive to H+; activated by change in pH produced by exercise, ischemia, inflammation. TRPV1 – sensitive to H+, lipids (anadamide), heat P2X3/5 – activated by ATP Evidence suggests interaction of receptor types on skeletal muscle afferent endings, e.g., P2X/ASICs Birdsong et al (2010) Sensing muscle ischemia: coincident detection of acid and ATP via interplay of two ion channels. Neuron 68:739. Models of Muscle Pain • Injection/continuous infusion of algogenic compounds: (carrageenan, mustard oil, immune modulators). • Acid model – Injection(s) of acidic saline causes mech allodynia via activation of acid sensing ion channels (ASICs). - Non-inflammatory - Inhibition of acid pain by opioids, NMDA blockers, pregabalin and exercise but not to NSAIDs. • Exercise induced: delayed onset of muscle soreness model. Produces micro tears that cause pain and increased lactate, glutamate, PGE2, SubP. • Exercise (wheel running) plus acid, e.g., pH 5 • Injection of metabolites produced by muscle contraction - combination of ATP, lactate, protons (H+) act synergistically to activate receptors. • Prolonged ischemia (e.g., 6h surgical occlusion, brachial artery) – models pain associated with conditions that can produce ischemia/reperfusion injuries: complex regional pain syndrome (CRPS), peripheral vascular disease (PVD), sickle cell anemia and fibromyalgia. • Clinical features of ischemic myalgia include decreased activity, ongoing pain, hypersensitivity, and weakness in the affected muscle tissue. In contrast to nociceptive stimuli from skin, muscle activity/pain can elicit a cardiovascular (exercise pressor) reflex, i.e., increased heart rate, blood pressure, sweating. Activation of Group III/IV afferents - transmit muscle pain and affect autonomic (sympathetic) responses. • Ablation/anesthetic block of group III/IV neurons abolishes the EPR in response to muscle contraction. • Patients with CRPS or vascular disease have exaggerated EPRs. • Both pain and change in cardiovascular reflexes in response to ischemic damage involves upregulation of P2Y1 in primary afferents. Queme, Ross and Jankowski. 2017. Peripheral mechanisms of ischemic myalgia. ischemic of 2017.mechanisms Peripheral Jankowski.and RossQueme, Neuroscience. in Cellular Frontiers Acid activates Acid Sensing Ion Channels (ASICs), a subfamily of the epithelial sodium channel (ENaC/degenerin) ion channel superfamily Voltage independent, proton-gated sodium channels that detect change in pH (5-8; tissue acidification) under pathological and non- pathological conditions: ischemia, fatiguing muscle exercise, cancer, neuronal activity, inflammation. ASICs1-5 genes have splice variants and protein isoforms. Most common ASIC1a, ASIC1a/2a, ASIC3. Studies support major role for ASIC3 in nociception: Injection of acid causes pain; pain is absent
Load more

Recommended publications
  • Download the Herniated Disc Brochure
    AN INTRODUCTION TO HERNIATED DISCS This booklet provides general information on herniated discs. It is not meant to replace any personal conversations that you might wish to have with your physician or other member of your healthcare team. Not all the information here will apply to your individual treatment or its outcome. About the Spine CERVICAL The human spine is comprised 24 bones or vertebrae in the cervical (neck) spine, the thoracic (chest) spine, and the lumbar (lower back) THORACIC spine, plus the sacral bones. Vertebrae are connected by several joints, which allow you to bend, twist, and carry loads. The main joint LUMBAR between two vertebrae is called an intervertebral disc. The disc is comprised of two parts, a tough and fibrous outer layer (annulus fibrosis) SACRUM and a soft, gelatinous center (nucleus pulposus). These two parts work in conjunction to allow the spine to move, and also provide shock absorption. INTERVERTEBRAL ANNULUS DISC FIBROSIS SPINAL NERVES NUCLEUS PULPOSUS Each vertebrae has an opening (vertebral foramen) through which a tubular bundle of spinal nerves and VERTEBRAL spinal nerve roots travel. FORAMEN From the cervical spine to the mid-lumbar spine this bundle of nerves is called the spinal cord. The bundle is then referred to as the cauda equina through the bottom of the spine. At each level of the spine, spinal nerves exit the spinal cord and cauda equina to both the left and right sides. This enables movement and feeling throughout the body. What is a Herniated Disc? When the gelatinous center of the intervertebral disc pushes out through a tear in the fibrous wall, the disc herniates.
    [Show full text]
  • Lower Back Pain in Athletes EXPERT CONSULTANTS: Timothy Hosea, MD, Monica Arnold, DO
    SPORTS TIP Lower Back Pain in Athletes EXPERT CONSULTANTS: Timothy Hosea, MD, Monica Arnold, DO How common is low back pain? What structures of the back Low back pain is a very common can cause pain? problem in industrialized countries, Low back pain can come from all the affecting over 70 percent of the working spinal structures. The bony elements population. Back pain is also common of the spine can develop stress fractures, in such sports as football, soccer, or in the older athlete, arthritic changes golf, rowing, and gymnastics. which may pinch the nerve roots. The annulus has a large number of pain What are the structures fibers, and any injury to this structure, of the back? such as a sprain, bulging disc, or disc The spine is composed of three regions herniation will result in pain. Finally, the from your neck to the lower back. surrounding muscles and ligaments may The cervical region corresponds also suffer an injury, leading to pain. to your neck, the thoracic region is the mid-back (or back of the chest), How is the lower back injured? and the lumbar area is the lower back. Injuries to the lower back can be the The lumbar area provides the most result of improper conditioning and motion and works the hardest in warm-up, repetitive loading patterns, supporting your weight, and enables excessive sudden loads, and twisting you to bend, twist, and lift. activities. Proper body mechanics and flexibility are essential for all activities. Each area of the spine is composed To prevent injury, it is important to learn of stacked bony vertebral bodies with the proper technique in any sporting interposed cushioning pads called discs.
    [Show full text]
  • Aetiology of Fibrositis
    Ann Rheum Dis: first published as 10.1136/ard.6.4.241 on 1 January 1947. Downloaded from AETIOLOGY OF FIBROSITIS: A REVIEW BY MAX VALENTINE From a review of systems of classification of fibrositis (National Mineral Water Hospital, Bath, 1940; Devonshire Royal Hospital, Buxton, 1940; Ministry of Health Report, 1924; Harrogate Royal Bath Hospital Report, 1940; Ray, 1934; Comroe, 1941 ; Patterson, 1938) the one in use at the National Mineral Water Hospital, Bath, is considered most valuable. There are five divisions of fibrositis as follows: (a) intramuscular, (b) periarticular, (c) bursal and tenosynovial, (d) subcutaneous, (e) perineuritic, the latter being divided into (i) brachial (ii) sciatic, etc. Laboratory Tests No biochemical abnormalities have been demonstrated in fibrositis. Mester (1941) claimed a specific test for " rheumatism ", but Copeman and Stewart (1942) did not find it of value and question its rationale. The sedimentation rate is usually normal or may be slightly increased; this is confirmed by Kahlmeter (1928), Sha;ckle (1938), and Dawson and others (1930). Miller copyright. and Gibson (1941) found a slightly increased rate in 52-3% of patients, and Collins and others (1939) found a (usually) moderately increased rate in 35% of cases tested. Case Analyses In an investigation Valentine (1943) found an incidence of fibrositis of 31-4% (60% male) at a Spa hospital. (Cf. Ministry of Health Report, 1922, 30-8%; Buxton Spa Hospital, 1940, 49 5%; Bath Spa Hospital, 1940, 22-3%; Savage, 1941, 52% in the Forces.) Fibrositis was commonest http://ard.bmj.com/ between the ages of40 and 60; this is supported by the SpaHospital Report, Buxton, 1940.
    [Show full text]
  • Guidline for the Evidence-Informed Primary Care Management of Low Back Pain
    Guideline for the Evidence-Informed Primary Care Management of Low Back Pain 2nd Edition These recommendations are systematically developed statements to assist practitioner and patient decisions about appropriate health care for specific clinical circumstances. They should be used as an adjunct to sound clinical decision making. Guideline Disease/Condition(s) Targeted Specifications Acute and sub-acute low back pain Chronic low back pain Acute and sub-acute sciatica/radiculopathy Chronic sciatica/radiculopathy Category Prevention Diagnosis Evaluation Management Treatment Intended Users Primary health care providers, for example: family physicians, osteopathic physicians, chiro- practors, physical therapists, occupational therapists, nurses, pharmacists, psychologists. Purpose To help Alberta clinicians make evidence-informed decisions about care of patients with non- specific low back pain. Objectives • To increase the use of evidence-informed conservative approaches to the prevention, assessment, diagnosis, and treatment in primary care patients with low back pain • To promote appropriate specialist referrals and use of diagnostic tests in patients with low back pain • To encourage patients to engage in appropriate self-care activities Target Population Adult patients 18 years or older in primary care settings. Exclusions: pregnant women; patients under the age of 18 years; diagnosis or treatment of specific causes of low back pain such as: inpatient treatments (surgical treatments); referred pain (from abdomen, kidney, ovary, pelvis,
    [Show full text]
  • Inflammatory Back Pain in Patients Treated with Isotretinoin Although 3 NSAID Were Administered, Her Complaints Did Not Improve
    Inflammatory Back Pain in Patients Treated with Isotretinoin Although 3 NSAID were administered, her complaints did not improve. She discontinued isotretinoin in the third month. Over 20 days her com- To the Editor: plaints gradually resolved. Despite the positive effects of isotretinoin on a number of cancers and In the literature, there are reports of different mechanisms and path- severe skin conditions, several disorders of the musculoskeletal system ways indicating that isotretinoin causes immune dysfunction and leads to have been reported in patients who are treated with it. Reactive seronega- arthritis and vasculitis. Because of its detergent-like effects, isotretinoin tive arthritis and sacroiliitis are very rare side effects1,2,3. We describe 4 induces some alterations in the lysosomal membrane structure of the cells, cases of inflammatory back pain without sacroiliitis after a month of and this predisposes to a degeneration process in the synovial cells. It is isotretinoin therapy. We observed that after termination of the isotretinoin thought that isotretinoin treatment may render cells vulnerable to mild trau- therapy, patients’ complaints completely resolved. mas that normally would not cause injury4. Musculoskeletal system side effects reported from isotretinoin treat- Activation of an infection trigger by isotretinoin therapy is complicat- ment include skeletal hyperostosis, calcification of tendons and ligaments, ed5. According to the Naranjo Probability Scale, there is a potential rela- premature epiphyseal closure, decreases in bone mineral density, back tionship between isotretinoin therapy and bilateral sacroiliitis6. It is thought pain, myalgia and arthralgia, transient pain in the chest, arthritis, tendonitis, that patients who are HLA-B27-positive could be more prone to develop- other types of bone abnormalities, elevations of creatine phosphokinase, ing sacroiliitis and back pain after treatment with isotretinoin, or that and rare reports of rhabdomyolysis.
    [Show full text]
  • Clinical Data Mining Reveals Analgesic Effects of Lapatinib in Cancer Patients
    www.nature.com/scientificreports OPEN Clinical data mining reveals analgesic efects of lapatinib in cancer patients Shuo Zhou1,2, Fang Zheng1,2* & Chang‑Guo Zhan1,2* Microsomal prostaglandin E2 synthase 1 (mPGES‑1) is recognized as a promising target for a next generation of anti‑infammatory drugs that are not expected to have the side efects of currently available anti‑infammatory drugs. Lapatinib, an FDA‑approved drug for cancer treatment, has recently been identifed as an mPGES‑1 inhibitor. But the efcacy of lapatinib as an analgesic remains to be evaluated. In the present clinical data mining (CDM) study, we have collected and analyzed all lapatinib‑related clinical data retrieved from clinicaltrials.gov. Our CDM utilized a meta‑analysis protocol, but the clinical data analyzed were not limited to the primary and secondary outcomes of clinical trials, unlike conventional meta‑analyses. All the pain‑related data were used to determine the numbers and odd ratios (ORs) of various forms of pain in cancer patients with lapatinib treatment. The ORs, 95% confdence intervals, and P values for the diferences in pain were calculated and the heterogeneous data across the trials were evaluated. For all forms of pain analyzed, the patients received lapatinib treatment have a reduced occurrence (OR 0.79; CI 0.70–0.89; P = 0.0002 for the overall efect). According to our CDM results, available clinical data for 12,765 patients enrolled in 20 randomized clinical trials indicate that lapatinib therapy is associated with a signifcant reduction in various forms of pain, including musculoskeletal pain, bone pain, headache, arthralgia, and pain in extremity, in cancer patients.
    [Show full text]
  • Anesthetic Or Corticosteroid Injections for Low Back Pain
    Anesthetic or Corticosteroid Injections for Low Back Pain Examples Trigger point injections. Sometimes, putting pressure on a certain spot in the back (called a trigger point) can cause pain at that spot or extending to another area of the body, such as the hip or leg. To try to relieve pain, a local anesthetic, either alone or combined with a corticosteroid, is injected into the area of the back that triggers pain (trigger point injection). Facet joint injections. A local anesthetic or corticosteroid is injected into a facet joint, which is one of the points where one vertebra connects to another. Epidural injections. A corticosteroid is injected into the spinal canal where it bathes the sheath that surrounds the spinal cord and nerve roots. These injections can be done by an orthopedist, an anesthesiologist, a neurologist, a physiatrist, a pain management specialist, or a rheumatologist. How It Works Local anesthesia is believed to break the cycle of pain that can cause you to become less physically active. Muscles that are not being exercised are more easily injured. Then the irritated and injured muscles can cause more pain and spasm and can disrupt sleep. This pain, spasm, and fatigue, in turn, can lead to less and less activity. Steroids reduce inflammation. So a corticosteroid injected into the spinal canal can help relieve pressure on nerves and nerve roots. Why It Is Used Injections may be tried if you have symptoms of nerve root compression or facet inflammation and you do not respond to nonsurgical therapy after 6 weeks. How Well It Works Research has not shown that local injections are effective in controlling low back pain that does not spread down the leg.footnote1 Side Effects All medicines have side effects.
    [Show full text]
  • Employees Calling About RTW Clearance
    1. Employee should do home quarantine for 7 days Employees calling and consult their physician about RTW clearance 2. Employee must call their own manager to call in Community/General Exposure OR sick as per their usual policy IP&C or Supervisor Confirmed Exposure 3. To return to work, employee must be fever-free without antipyretic for 3 days (72 hours) AND 1. Confirm that employee symptoms improveD AND finisheD 7-day home has finished 7-day home quarantine Community/General/ Travel/ quarantine AND fever-free Day Zero= First Day of Symptoms without antipyretics for 3 CDC Level 2/3 Country* COVID Permitted work on the 8th day days (72 hours) AND Exposure Employee must call the WHS hotline back symptoms have improved then for RTW clearance Employees who call-in 2. Employee should wear Community/General/ 4.Fill out RTW form to place employee off-duty with non-CLI surgical face mask during Unknown COVID Symptoms, but still entire shift while at work exposure (any not feeling well: going forward 3. If employee has been off- exposure that is NOT Please remember to stay duty for 8 or more calendar “Infection Prevention home if you don’t feel days, then email and Control (IP&C) well. Healthcare team confirmed) [email protected] Personnel must not work with doctor’s note simply sick. Follow usual steps stating that they sought for take sick day and care/treatment for COVID- contact their manager. Note: loss of smell/taste alone does If there are NO like symptoms ANY 4.Employee should update NOT constitute CLI per WHS No RTW form needed for symptoms following their manager COVID-19 Symptoms: guidelines Employees with NO non-CLI exposure or travel, 5.
    [Show full text]
  • Oral Health Fact Sheet for Dental Professionals Adults with Type 2 Diabetes
    Oral Health Fact Sheet for Dental Professionals Adults with Type 2 Diabetes Type 2 Diabetes ranges from predominantly insulin resistant with relative insulin deficiency to predominantly an insulin secretory defect with insulin resistance, American Diabetes Association, 2010. (ICD 9 code 250.0) Prevalence • 23.6 million Americans have diabetes – 7.8% of U.S. population. Of these, 5.7 million do not know they have the disease. • 1.6 million people ≥20 years of age are diagnosed with diabetes annually. • 90–95% of diabetic patients have Type 2 Diabetes. Manifestations Clinical of untreated diabetes • High blood glucose level • Excessive thirst • Frequent urination • Weight loss • Fatigue Oral • Increased risk of dental caries due to salivary hypofunction • Accelerated tooth eruption with increasing age • Gingivitis with high risk of periodontal disease (poor control increases risk) • Salivary gland dysfunction leading to xerostomia • Impaired or delayed wound healing • Taste dysfunction • Oral candidiasis • Higher incidence of lichen planus Other Potential Disorders/Concerns • Ketoacidosis, kidney failure, gastroparesis, diabetic neuropathy and retinopathy • Poor circulation, increased occurrence of infections, and coronary heart disease Management Medication The list of medications below are intended to serve only as a guide to facilitate the dental professional’s understanding of medications that can be used for Type 2 Diabetes. Medical protocols can vary for individuals with Type 2 Diabetes from few to multiple medications. ACTION TYPE BRAND NAME/GENERIC SIDE EFFECTS Enhance insulin Sulfonylureas Glipizide (Glucotrol) Angioedema secretion Glyburide (DiaBeta, Fluconazoles may increase the Glynase, Micronase) hypoglycemic effect of glipizide Glimepiride (Amaryl) and glyburide. Tolazamide (Tolinase, Corticosteroids may produce Diabinese, Orinase) hyperglycemia. Floxin and other fluoroquinolones may increase the hypoglycemic effect of sulfonylureas.
    [Show full text]
  • Mechanical Low Back Pain Joshua Scott Will, DO; ​David C
    Mechanical Low Back Pain Joshua Scott Will, DO; David C. Bury, DO; and John A. Miller, DPT Martin Army Community Hospital, Fort Benning, Georgia Low back pain is usually nonspecific or mechanical. Mechanical low back pain arises intrinsically from the spine, interverte- bral disks, or surrounding soft tissues. Clinical clues, or red flags, may help identify cases of nonmechanical low back pain and prompt further evaluation or imaging. Red flags include progressive motor or sensory loss, new urinary retention or overflow incontinence, history of cancer, recent invasive spinal procedure, and significant trauma relative to age. Imaging on initial presentation should be reserved for when there is suspicion for cauda equina syndrome, malignancy, fracture, or infection. Plain radiography of the lumbar spine is appropriate to assess for fracture and bony abnormality, whereas magnetic resonance imaging is better for identifying the source of neurologic or soft tissue abnormalities. There are multiple treatment modalities for mechanical low back pain, but strong evidence of benefit is often lacking. Moderate evidence supports the use of nonsteroidal anti-inflammatory drugs, opioids, and topiramate in the short-term treatment of mechanical low back pain. There is little or no evidence of benefit for acetamin- ophen, antidepressants (except duloxetine), skeletal muscle relaxants, lidocaine patches, and transcutaneous electrical nerve stimulation in the treatment of chronic low back pain. There is strong evidence for short-term effectiveness and moderate-quality evidence for long-term effectiveness of yoga in the treatment of chronic low back pain. Various spinal manipulative techniques (osteopathic manipulative treatment, spinal manipulative therapy) have shown mixed benefits in the acute and chronic setting.
    [Show full text]
  • Diagnosis and Treatment of Lumbar Disc Herniation with Radiculopathy
    Y Lumbar Disc Herniation with Radiculopathy | NASS Clinical Guidelines 1 G Evidence-Based Clinical Guidelines for Multidisciplinary ETHODOLO Spine Care M NE I DEL I U /G ON Diagnosis and Treatment of I NTRODUCT Lumbar Disc I Herniation with Radiculopathy NASS Evidence-Based Clinical Guidelines Committee D. Scott Kreiner, MD Paul Dougherty, II, DC Committee Chair, Natural History Chair Robert Fernand, MD Gary Ghiselli, MD Steven Hwang, MD Amgad S. Hanna, MD Diagnosis/Imaging Chair Tim Lamer, MD Anthony J. Lisi, DC John Easa, MD Daniel J. Mazanec, MD Medical/Interventional Treatment Chair Richard J. Meagher, MD Robert C. Nucci, MD Daniel K .Resnick, MD Rakesh D. Patel, MD Surgical Treatment Chair Jonathan N. Sembrano, MD Anil K. Sharma, MD Jamie Baisden, MD Jeffrey T. Summers, MD Shay Bess, MD Christopher K. Taleghani, MD Charles H. Cho, MD, MBA William L. Tontz, Jr., MD Michael J. DePalma, MD John F. Toton, MD This clinical guideline should not be construed as including all proper methods of care or excluding or other acceptable methods of care reason- ably directed to obtaining the same results. The ultimate judgment regarding any specific procedure or treatment is to be made by the physi- cian and patient in light of all circumstances presented by the patient and the needs and resources particular to the locality or institution. I NTRODUCT 2 Lumbar Disc Herniation with Radiculopathy | NASS Clinical Guidelines I ON Financial Statement This clinical guideline was developed and funded in its entirety by the North American Spine Society (NASS). All participating /G authors have disclosed potential conflicts of interest consistent with NASS’ disclosure policy.
    [Show full text]
  • Chronic Pelvic Pain & Pelvic Floor Myalgia Updated
    Welcome to the chronic pelvic pain and pelvic floor myalgia lecture. My name is Dr. Maria Giroux. I am an Obstetrics and Gynecology resident interested in urogynecology. This lecture was created with Dr. Rashmi Bhargava and Dr. Huse Kamencic, who are gynecologists, and Suzanne Funk, a pelvic floor physiotherapist in Regina, Saskatchewan, Canada. We designed a multidisciplinary training program for teaching the assessment of the pelvic floor musculature to identify a possible muscular cause or contribution to chronic pelvic pain and provide early referral for appropriate treatment. We then performed a randomized trial to compare the effectiveness of hands-on vs video-based training methods. The results of this research study will be presented at the AUGS/IUGA Joint Scientific Meeting in Nashville in September 2019. We found both hands-on and video-based training methods are effective. There was no difference in the degree of improvement in assessment scores between the 2 methods. Participants found the training program to be useful for clinical practice. For both versions, we have designed a ”Guide to the Assessment of the Pelvic Floor Musculature,” which are cards with the anatomy of the pelvic floor and step-by step instructions of how to perform the assessment. In this lecture, we present the video-based training program. We have also created a workshop for the hands-on version. For more information about our research and workshop, please visit the website below. This lecture is designed for residents, fellows, general gynecologists,
    [Show full text]